Health Net, Inc. (Health Net) is a managed care organization. The Company provides managed health care services through health plans and government-sponsored managed care plans. Its segments are Western Region Operations and Government Contracts. It provides and administers health benefits to approximately 6 million individuals across the United States through group, individual, Medicare, Medicaid, dual eligible, the United States Department of Defense (Department of Defense or DoD), including TRICARE, and the United States Department of Veterans Affairs programs. Through its subsidiaries, it also offers behavioral health, substance abuse and employee assistance programs, managed health care products related to prescription drugs, managed health care product coordination for multi-region employers, and administrative services for medical groups and self-funded benefits programs.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: HMO Medical Centers
- Sub-Industry: Managed Health Care
- Symbol: NYSE:HNT
- CUSIP: 42222G10
- Web: https://www.healthnet.com
Capitalization:- Market Cap: $5.19 billion
- Outstanding Shares: 77,301,000
Average Prices:- 50 Day Moving Avg: $62.94
- 200 Day Moving Avg: $64.16
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 15.24
- P/E Growth: 0.00
Profitability:- Net Margins: 0.92%
- Return on Equity: 8.21%
- Return on Assets: 2.39%
Frequently Asked Questions for Health Net (NYSE:HNT)
What is Health Net's stock symbol?
Health Net trades on the New York Stock Exchange (NYSE) under the ticker symbol "HNT."
How were Health Net's earnings last quarter?
Health Net, Inc. (NYSE:HNT) released its earnings results on Thursday, February, 25th. The company reported $0.47 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.66 by $0.19. The company earned $4.04 billion during the quarter, compared to the consensus estimate of $4.20 billion. Health Net had a net margin of 0.92% and a return on equity of 8.21%. View Health Net's Earnings History.
Who are some of Health Net's key competitors?
Some companies that are related to Health Net include Omnicare (OCR), VCA (WOOF), Valeant Pharmaceuticals Intl (VRX), NMC Health PLC (NMC), ConvaTec Group PLC (CTEC), Catalent (CTLT), Patheon NV (PTHN), Mediclinic International PLC (MDC), Puma Biotechnology (PBYI), Cotiviti Holdings (COTV), WuXi PharmaTech (Cayman) (WX), Enerplus Corp (ERF), Hikma Pharmaceuticals Plc (HIK), Axovant Sciences Ltd (AXON), BTG plc (BTG), Indivior PLC (INDV), Hutchison China MediTech Limited (HCM) and Abcam Plc (ABC).
How do I buy Health Net stock?
Shares of Health Net can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Health Net's stock price today?
One share of Health Net stock can currently be purchased for approximately $67.19.
MarketBeat Community Rating for Health Net (NYSE HNT)MarketBeat's community ratings are surveys of what our community members think about Health Net and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Health Net (NYSE:HNT)Earnings History by Quarter for Health Net (NYSE HNT)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/25/2016 | Q4 | $0.66 | $0.47 | $4.20 billion | $4.04 billion | View | N/A |  |
| 11/2/2015 | Q315 | $0.96 | $0.96 | $4.35 billion | $4.15 billion | View | N/A | |
| 8/4/2015 | Q215 | $0.89 | $0.95 | $4.21 billion | $4.16 billion | View | Listen | |
| 5/4/2015 | Q115 | $0.69 | $0.74 | $4.12 billion | $3.89 billion | View | Listen | |
| 2/10/2015 | Q414 | $0.57 | $0.65 | $3.97 billion | $3.76 billion | View | Listen | |
| 11/3/2014 | Q314 | $0.73 | $0.75 | $3.71 billion | $3.79 billion | View | Listen | |
| 8/6/2014 | Q214 | $0.56 | $0.62 | $3.40 billion | $3.42 billion | View | Listen | |
| 5/7/2014 | Q114 | $0.42 | $0.39 | $3.25 billion | $3.04 billion | View | Listen | |
| 2/11/2014 | Q413 | $0.29 | $0.25 | $2.75 billion | $2.74 billion | View | Listen | |
| 7/25/2013 | Q2 2013 | $0.52 | $0.52 | $2.74 billion | $2.74 billion | View | Listen | |
| 4/29/2013 | Q1 2013 | $0.41 | $0.62 | $2.78 billion | $2.80 billion | View | Listen | |
| 1/30/2013 | Q4 2012 | $0.38 | $0.06 | $2.77 billion | $2.83 billion | View | Listen | |
| 11/5/2012 | Q312 | $0.37 | $0.38 | $2.80 billion | $2.78 billion | View | N/A | |
| 8/3/2012 | | $0.67 | $0.19 | | | View | N/A | |
| 5/3/2012 | | $0.60 | ($0.32) | | | View | N/A | |
| 2/3/2012 | | $0.89 | $0.90 | | | View | N/A | |
| 11/2/2011 | | $0.84 | $0.85 | | | View | N/A | |
| 8/4/2011 | | $0.70 | $0.76 | | | View | N/A | |
| 5/4/2011 | | $0.57 | $0.61 | | | View | N/A | |
| 2/1/2011 | | $0.78 | $0.83 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Health Net (NYSE:HNT)2017 EPS Consensus Estimate: $4.56
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.99 | $0.99 | $0.99 |
| Q2 2017 | 1 | $1.24 | $1.24 | $1.24 |
| Q3 2017 | 1 | $1.32 | $1.32 | $1.32 |
| Q4 2017 | 2 | $0.99 | $1.02 | $1.01 |
(Data provided by Zacks Investment Research)
Dividend History for Health Net (NYSE:HNT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Health Net (NYSE:HNT)Insider Trades by Quarter for Health Net (NYSE:HNT)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/29/2015 | Vicki B Escarra | Director | Sell | 3,109 | $63.31 | $196,830.79 | |
| 6/26/2015 | Marie Montgomery | SVP | Sell | 1,872 | $65.00 | $121,680.00 | |
| 6/26/2015 | Steven D Tough | Insider | Sell | 34,200 | $64.83 | $2,217,186.00 | |
| 6/24/2015 | Bruce G Willison | Director | Sell | 4,173 | $64.57 | $269,450.61 | |
| 6/22/2015 | Bruce G Willison | Director | Sell | 3,109 | $64.64 | $200,965.76 | |
| 6/19/2015 | Steven D Tough | Insider | Sell | 35,000 | $63.49 | $2,222,150.00 | |
| 6/5/2015 | James Woys | CFO | Sell | 18,000 | $60.47 | $1,088,460.00 | |
| 4/15/2015 | James Woys | CFO | Sell | 34,000 | $57.41 | $1,951,940.00 | |
| 4/6/2015 | Juanell Hefner | Insider | Sell | 24,919 | $60.04 | $1,496,136.76 | |
| 4/6/2015 | Marie Montgomery | SVP | Sell | 52,238 | $60.03 | $3,135,847.14 | |
| 3/31/2015 | James Woys | CFO | Sell | 34,000 | $60.61 | $2,060,740.00 | |
| 3/30/2015 | Gale S Fitzgerald | Director | Sell | 18,500 | $60.48 | $1,118,880.00 | |
| 3/30/2015 | James Woys | CFO | Sell | 17,000 | $60.76 | $1,032,920.00 | |
| 3/9/2015 | Angelee F Bouchard | SVP | Sell | 7,258 | $55.99 | $406,375.42 | |
| 3/9/2015 | Steven Sell | Insider | Sell | 6,038 | $56.00 | $338,128.00 | |
| 2/23/2015 | Angelee F Bouchard | SVP | Sell | 1,246 | $56.45 | $70,336.70 | |
| 2/23/2015 | Steven Sell | Insider | Sell | 1,820 | $56.45 | $102,739.00 | |
| 2/18/2015 | Angelee F Bouchard | SVP | Sell | 1,965 | $55.95 | $109,941.75 | |
| 2/18/2015 | Steven Sell | Insider | Sell | 1,797 | $55.95 | $100,542.15 | |
| 12/31/2014 | Angelee F Bouchard | SVP | Sell | 3,800 | $55.00 | $209,000.00 | |
| 12/18/2014 | Juanell Hefner | Insider | Sell | 12,000 | $53.00 | $636,000.00 | |
| 12/15/2014 | Angelee F Bouchard | SVP | Sell | 2,501 | $51.78 | $129,501.78 | |
| 11/18/2014 | Steven Sell | Insider | Sell | 26,350 | $52.00 | $1,370,200.00 | |
| 11/13/2014 | Juanell Hefner | Insider | Sell | 2,500 | $50.00 | $125,000.00 | |
| 11/13/2014 | Karin D Mayhew | SVP | Sell | 32,500 | $50.00 | $1,625,000.00 | |
| 10/22/2014 | Juanell Hefner | Insider | Sell | 2,400 | $48.00 | $115,200.00 | |
| 10/6/2014 | Steven D Tough | Insider | Sell | 8,000 | $46.76 | $374,080.00 | |
| 9/29/2014 | Steven D Tough | Insider | Sell | 10,000 | $45.95 | $459,500.00 | |
| 9/29/2014 | Vicki B Escarra | Director | Sell | 36,293 | $46.40 | $1,683,995.20 | |
| 9/25/2014 | Gale S Fitzgerald | Director | Sell | 7,500 | $46.70 | $350,250.00 | |
| 9/24/2014 | Karin D Mayhew | SVP | Sell | 47,814 | $46.48 | $2,222,394.72 | |
| 9/23/2014 | Karin D Mayhew | SVP | Sell | 81,811 | $46.31 | $3,788,667.41 | |
| 9/22/2014 | Angelee F Bouchard | SVP | Sell | 46,704 | $46.57 | $2,175,005.28 | |
| 9/22/2014 | Steven D Tough | Insider | Sell | 10,000 | $46.90 | $469,000.00 | |
| 9/19/2014 | Frederick C Yeager | Director | Sell | 4,000 | $47.69 | $190,760.00 | |
| 9/19/2014 | Juanell Hefner | Insider | Sell | 45,858 | $47.30 | $2,169,083.40 | |
| 9/15/2014 | Steven D Tough | Insider | Sell | 10,000 | $46.09 | $460,900.00 | |
| 9/11/2014 | Steven Sell | Insider | Sell | 117,273 | $46.58 | $5,462,576.34 | |
| 2/13/2013 | James Woys | COO | Sell | 15,000 | $27.84 | $417,600.00 | |
| 2/13/2013 | Patricia T Clarey | SVP | Sell | 10,000 | $27.84 | $278,400.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Health Net (NYSE:HNT)
Latest Headlines for Health Net (NYSE:HNT)
| Source: |
|
Health Net (HNT) Chart for Saturday, September, 23, 2017
